Case | Age and Gender | Time | Dose | Pathology | sIL-2R | SUVmax | Lesions | |
| (y) | (mo) | (mg/week) |
| (U/ml) |
| Nodal | Extranodal |
1 | 57F | 54 | NA | MALT | 894 | 3.6 | 0 | 1 |
2 | 74F | 120 | 6 | DLBCL | 918 | 21.2 | 1 | 6 |
3 | 75F | 63 | 8.75 | Hodgkin | 1942 | 10.6 | 2 | 1 |
4 | 69M | 81 | 15 | DLBCL | 1170 | 31.3 | 0 | 1 |
5 | 71F | 70 | 6 | DLBCL | 889 | 12.2 | 4 | 2 |
6 | 69F | 59 | 8 | Hodgkin | 4911 | 14.8 | 10 | 1 |
7 | 72F | 84 | 8 | PTCL | 1498 | 7.6 | 4 | 1 |
8 | 67F | 25 | 8 | Hodgkin | 12653 | 11.8 | 9 | 1 |
9 | 64F | 56 | 6 | DLBCL | 1041 | 4.2 | 0 | 1 |
10 | 75F | 30 | 6 | DLBCL | 475 | 10.3 | 3 | 1 |
11 | 61M | 18 | 12 | DLBCL | 2283 | 32.8 | 4 | 2 |